Focused on developing novel technologies that restore physiological balance in apoptosis-related diseases
Tamarix-Pharma is a dynamic biotechnology research company dedicated to pioneering novel technologies that restore physiological balance in apoptosis-related diseases. With a focus on innovation and scientific excellence, Tamarix-Pharma is committed to developing groundbreaking solutions for a variety of acute and chronic conditions resulting from apoptotic cell death.
Located in Tel Aviv, Tamarix-Pharma's lead assets, VBIT-4 and VBIT-12, are uniquely designed to target a key mitochondrial process known as VDAC1 oligomerization. This differentiated approach underscores Tamarix-Pharma's commitment to addressing significant unmet medical needs through cutting-edge research and development.
Tamarix-Pharma is poised for continued growth and success in the biotechnology sector. We invite the manager of Tamarix-Pharma to create a customized and exclusive company showcase and product listing on our platform to further enhance their visibility and commercial opportunities.
Other organizations in the same industry
This company is also known as